Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


06.11.2017

1 Ann Oncol
7 Ann Surg Oncol
2 Anticancer Res
5 BMC Cancer
1 Br J Cancer
3 Br J Surg
1 Cancer Lett
4 Cancer Res
1 Clin Cancer Res
14 Gastrointest Endosc
4 Gut
1 Int J Cancer
2 Int J Oncol
1 J Clin Oncol
2 J Surg Oncol
2 Lancet Gastroenterol Hepatol
1 Oncogene
3 PLoS One
2 Proc Natl Acad Sci U S A
2 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. OVERMAN M, Adam L, Raghav K, Wang J, et al
    Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
    Ann Oncol. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    PubMed     Text format    

  3. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    PubMed     Text format     Abstract available

  4. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    PubMed     Text format     Abstract available

  5. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    PubMed     Text format    

  6. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    PubMed     Text format    

  7. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    PubMed     Text format     Abstract available

  8. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    PubMed     Text format    


    Anticancer Res

  9. BAR JK, Lis-Nawara A, Grelewski P, Noga L, et al
    The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to KRAS Gene Status.
    Anticancer Res. 2017;37:4953-4960.
    PubMed     Text format     Abstract available

  10. CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
    Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
    Anticancer Res. 2017;37:6489-6494.
    PubMed     Text format     Abstract available


    BMC Cancer

  11. PAHLE J, Menzel L, Niesler N, Kobelt D, et al
    Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
    BMC Cancer. 2017;17:129.
    PubMed     Text format     Abstract available

  12. LELONG B, de Chaisemartin C, Meillat H, Cournier S, et al
    A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.
    BMC Cancer. 2017;17:253.
    PubMed     Text format     Abstract available

  13. STEVENS JR, Herrick JS, Wolff RK, Slattery ML, et al
    Identifying factors associated with the direction and significance of microRNA tumor-normal expression differences in colorectal cancer.
    BMC Cancer. 2017;17:707.
    PubMed     Text format     Abstract available

  14. LI X, Lu H, Xu K, Wang H, et al
    Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy.
    BMC Cancer. 2017;17:227.
    PubMed     Text format     Abstract available

  15. RATJEN I, Schafmayer C, di Giuseppe R, Waniek S, et al
    Postdiagnostic physical activity, sleep duration, and TV watching and all-cause mortality among long-term colorectal cancer survivors: a prospective cohort study.
    BMC Cancer. 2017;17:701.
    PubMed     Text format     Abstract available


    Br J Cancer

  16. COOPER JA, Parsons N, Stinton C, Mathews C, et al
    Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model.
    Br J Cancer. 2017 Nov 2. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Surg

  17. NITSCHE U, Stoss C, Stecher L, Wilhelm D, et al
    Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
    Br J Surg. 2017 Oct 31. doi: 10.1002/bjs.10682.
    PubMed     Text format     Abstract available

  18. CREAVIN B, Kelly ME, Ryan E, Winter DC, et al
    Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.
    Br J Surg. 2017;104:1609-1619.
    PubMed     Text format     Abstract available

  19. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
    Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
    Br J Surg. 2017;104:1640-1647.
    PubMed     Text format     Abstract available


    Cancer Lett

  20. KIM C, Hong Y, Lee H, Kang H, et al
    MicroRNA-195 Desensitizes HCT116 Human Colon Cancer Cells to 5-Fluorouracil.
    Cancer Lett. 2017 Oct 25. pii: S0304-3835(17)30659.
    PubMed     Text format     Abstract available


    Cancer Res

  21. TAKADA M, Zhang W, Suzuki A, Kuroda TS, et al
    FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A.
    Cancer Res. 2017;77:4881-4893.
    PubMed     Text format     Abstract available

  22. TANG YC, Yuwen H, Wang K, Bruno PM, et al
    Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.
    Cancer Res. 2017;77:5272-5286.
    PubMed     Text format     Abstract available

  23. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    PubMed     Text format     Abstract available


  24. Correction: A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer.
    Cancer Res. 2017;77:6048.
    PubMed     Text format    


    Clin Cancer Res

  25. GROTHEY A, Strosberg JR, Renfro LA, Hurwitz HI, et al
    A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Ontuxizumab (MORAb-004) in Patients with Chemorefractory Metastatic Colorectal Cancer.
    Clin Cancer Res. 2017 Oct 30. pii: clincanres.1558.2017.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  26. MOAVEN J, Shami VM
    Predicting pathologic response: the "bottom line" in the management of locally advanced rectal cancer.
    Gastrointest Endosc. 2017;85:675-676.
    PubMed     Text format    

  27. ALMARIO CV, Spiegel BM
    Does endoscopist fatigue impact adenoma detection rate? A review of the evidence to date.
    Gastrointest Endosc. 2017;85:611-613.
    PubMed     Text format    

  28. WESTON BR, Ross WA
    Quality metrics: beyond adenoma detection rate.
    Gastrointest Endosc. 2017;85:588-589.
    PubMed     Text format    

  29. REX DK, Hassan C, Dewitt JM
    Colorectal endoscopic submucosal dissection in the United States: Why do we hear so much about it and do so little of it?
    Gastrointest Endosc. 2017;85:554-558.
    PubMed     Text format    

  30. KANTH P, Samadder NJ, DiSario J
    Duodenal adenomas in sporadic and familial adenomatous polyposis patients: Birds of a feather?
    Gastrointest Endosc. 2017;85:813-815.
    PubMed     Text format    

  31. HEWETT DG, Sakata S
    Classifications for optical diagnosis of colorectal lesions: not 2B with JNET.
    Gastrointest Endosc. 2017;85:822-828.
    PubMed     Text format    

  32. RUIZ-REBOLLO ML
    Postcolonoscopy colorectal carcinoma.
    Gastrointest Endosc. 2017;85:1113.
    PubMed     Text format    

  33. MANKANEY G, Burke CA
    Risk of metachronous advanced neoplasia in patients with diminutive versus small tubular adenomas: Is the juice worth the squeeze?
    Gastrointest Endosc. 2017;86:722-723.
    PubMed     Text format    

  34. SAITO Y, Bhatt A, Matsuda T
    Colorectal endoscopic submucosal dissection and its journey to the West.
    Gastrointest Endosc. 2017;86:90-92.
    PubMed     Text format    

  35. KANTSEVOY SV
    Stenosis after colorectal endoscopic submucosal dissection: When to expect, how to manage?
    Gastrointest Endosc. 2017;86:370-371.
    PubMed     Text format    

  36. HEITMAN SJ, Bourke MJ
    Endoscopic submucosal dissection and EMR for large colorectal polyps: "the perfect is the enemy of good".
    Gastrointest Endosc. 2017;86:87-89.
    PubMed     Text format    

  37. PETRINI JL JR
    Colonoscopy surveillance intervals: we are not there yet.
    Gastrointest Endosc. 2017;85:1271-1272.
    PubMed     Text format    

  38. CHAWLA S, Qayed E
    Learning curve for EMR of large nonpolypoid colorectal neoplasia: an alternative analysis method using longitudinal models.
    Gastrointest Endosc. 2017;85:1309-1310.
    PubMed     Text format    

  39. RAHMAN I, Patel P
    Avulsion for the treatment of visible residual neoplasia during EMR of colorectal polyps: Is "heat" required?
    Gastrointest Endosc. 2017;86:250-251.
    PubMed     Text format    


    Gut

  40. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Text format     Abstract available

  41. BEAULIEU JF
    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    PubMed     Text format    

  42. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Text format     Abstract available

  43. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Text format     Abstract available


    Int J Cancer

  44. FENG HC, Lin JY, Hsu SH, Lan WY, et al
    Low folate metabolic stress reprograms DNA methylation-activated sonic hedgehog signaling to mediate cancer stem cell-like signatures and invasive tumour stage-specific malignancy of human colorectal cancers.
    Int J Cancer. 2017;141:2537-2550.
    PubMed     Text format     Abstract available


    Int J Oncol

  45. KIM SL, Park YR, Lee ST, Kim SW, et al
    Parthenolide suppresses hypoxia-inducible factor-1alpha signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    Int J Oncol. 2017 Oct 18. doi: 10.3892/ijo.2017.4166.
    PubMed     Text format     Abstract available

  46. DACHINENI R, Kumar DR, Callegari E, Kesharwani SS, et al
    Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4167.
    PubMed     Text format     Abstract available


    J Clin Oncol

  47. WHITNEY RL, Bell JF, Tancredi DJ, Romano PS, et al
    Hospitalization Rates and Predictors of Rehospitalization Among Individuals With Advanced Cancer in the Year After Diagnosis.
    J Clin Oncol. 2017;35:3610-3617.
    PubMed     Text format     Abstract available


    J Surg Oncol

  48. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    PubMed     Text format    

  49. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  50. LORDICK F
    Changing paradigms in adjuvant treatment of colorectal cancer.
    Lancet Gastroenterol Hepatol. 2017 Oct 24. pii: S2468-1253(17)30332.
    PubMed     Text format    

  51. HAMAGUCHI T, Shimada Y, Mizusawa J, Kinugasa Y, et al
    Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
    Lancet Gastroenterol Hepatol. 2017 Oct 24. pii: S2468-1253(17)30297.
    PubMed     Text format     Abstract available


    Oncogene

  52. SCHROYER AL, Stimes NW, Abi Saab WF, Chadee DN, et al
    MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  53. MYUNG DS, Kweon SS, Lee J, Shin IS, et al
    Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).
    PLoS One. 2017;12:e0184205.
    PubMed     Text format     Abstract available

  54. SCOTT AJ, Song EK, Bagby S, Purkey A, et al
    Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
    PLoS One. 2017;12:e0187173.
    PubMed     Text format     Abstract available

  55. ROSWALL N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, et al
    Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.
    PLoS One. 2017;12:e0187161.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  56. XUE X, Bredell BX, Anderson ER, Martin A, et al
    Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201712946.
    PubMed     Text format     Abstract available

  57. GU C, Nguyen HN, Ganini D, Chen Z, et al
    KO of 5-InsP7 kinase activity transforms the HCT116 colon cancer cell line into a hypermetabolic, growth-inhibited phenotype.
    Proc Natl Acad Sci U S A. 2017 Oct 25. pii: 201702370.
    PubMed     Text format     Abstract available


    World J Surg

  58. OGURA A, Akiyoshi T, Nagasaki T, Konishi T, et al
    Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    World J Surg. 2017;41:868-875.
    PubMed     Text format     Abstract available

  59. NAGASAKI T, Akiyoshi T, Fujimoto Y, Konishi T, et al
    Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    World J Surg. 2017;41:876-883.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: